|
UBE2E1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.277400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.295400E-01 |
| Normal-vs-Stage2 |
7.017800E-01 |
| Normal-vs-Stage3 |
9.550800E-01 |
| Normal-vs-Stage4 |
3.342600E-01 |
| Stage1-vs-Stage2 |
5.687200E-01 |
| Stage1-vs-Stage3 |
8.951400E-01 |
| Stage1-vs-Stage4 |
2.707800E-01 |
| Stage2-vs-Stage3 |
7.225600E-01 |
| Stage2-vs-Stage4 |
5.618800E-01 |
| Stage3-vs-Stage4 |
4.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.457200E-01 |
| Normal-vs-AfricanAmerican |
6.065800E-01 |
| Normal-vs-Asian |
7.652400E-01 |
| Caucasian-vs-AfricanAmerican |
4.030200E-01 |
| Caucasian-vs-Asian |
7.742200E-01 |
| AfricanAmerican-vs-Asian |
9.907000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.339200E-01 |
| Normal-vs-Female |
1.354380E-01 |
| Male-vs-Female |
1.136480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.677800E-01 |
| Normal-vs-Extreme_Weight |
6.900800E-01 |
| Normal-vs-Obese |
8.966000E-01 |
| Normal-vs-Extreme_Obese |
3.519600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.321400E-01 |
| Normal_Weight-vs-Obese |
9.487600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.669400E-01 |
| Extreme_Weight-vs-Obese |
5.130200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.947400E-01 |
| Obese-vs-Extreme_Obese |
3.130800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.843990E-02 |
| Normal-vs-Age(41-60Yrs) |
7.443200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.489400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.642600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.905800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.357600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.875800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.280200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.111800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.183200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.971000E-01 |
| Normal-VS-Type2 PRCC |
2.016100E-02 |
| Normal-VS-KIRP CIMP |
4.031700E-04 |
| Normal-VS-Unclassified PRCC |
7.632200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.62330000000366E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.446800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.643000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.07109999986288E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.173900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.598500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.078100E-02 |
| Normal-vs-N1 |
2.889200E-01 |
| Normal-vs-N2 |
6.638600E-01 |
| N0-vs-N1 |
3.035300E-03 |
| N0-vs-N2 |
6.858000E-01 |
| N1-vs-N2 |
3.841600E-01 |
|
|
